Related Experiment Video
Updated: Jun 18, 2026

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
Published on: May 30, 2019
Hospitalization Costs and Clinical Burden of Rotavirus Gastroenteritis in Children Under Five: A Retrospective Study
Pelin Yücesan Şahin1, Gülnihan Üstündağ2, Ahu Kara Aksay2
1Department of Pediatrics, Izmir Tepecik Training and Research Hospital, İzmir, Türkiye.
Insights
Rotavirus gastroenteritis significantly impacts young children, causing hospitalizations and costs. Vaccination is not yet widespread, but rotavirus vaccine costs are lower than hospitalization expenses, suggesting cost-effectiveness.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Rotavirus is a leading cause of acute gastroenteritis and hospitalization in young children globally.
- Widespread rotavirus vaccination is not yet implemented in many regions, leaving populations vulnerable.
- Understanding the clinical and economic burden of rotavirus gastroenteritis is crucial for public health interventions.
Purpose of the Study:
- To evaluate the demographics, clinical outcomes, length of stay, vaccination status, and direct medical costs associated with rotavirus gastroenteritis in hospitalized children.
- To assess the potential cost-effectiveness of rotavirus vaccination in the context of current hospitalization costs.
Main Methods:
- Retrospective hospital-based study of children aged 1 month to 5 years with laboratory-confirmed rotavirus gastroenteritis.
- Data collected included patient demographics, clinical presentation, treatment, length of hospital stay, and direct medical costs.
- Analysis of vaccination status and comparison of vaccine prices with median hospitalization costs.
Main Results:
- A total of 540 rotavirus-positive children were included; 77 were hospitalized, with a median age of 8 months.
- The median hospital stay was 6 days, and the median hospitalization cost was $125.
- None of the studied children had received rotavirus vaccination, and hospitalization costs were higher for stays exceeding 7 days.
Conclusions:
- Rotavirus gastroenteritis imposes a significant clinical and economic burden on young children requiring hospitalization.
- The cost of rotavirus vaccination is comparable to or lower than the median hospitalization costs, supporting its inclusion in national immunization programs.
- Implementing rotavirus vaccination could be a cost-effective strategy to reduce childhood gastroenteritis burden and healthcare expenditures.
Abstract:
Rotavirus remains a major cause of acute gastroenteritis and hospitalization among young children worldwide, particularly where routine vaccination is not widely implemented. This retrospective hospital-based study evaluated children aged 1 month to 5 years hospitalized with laboratory-confirmed rotavirus gastroenteritis, focusing on demographics, clinical outcomes, length of stay, vaccination status, and direct medical costs. Among 540 rotavirus-positive children, 434 were outpatients, 20 received day-care treatment, and 77 were hospitalized. The median age was 8 months; 88.3% were younger than 24 months, and admissions clustered in spring and winter. The median hospital stay was 6 days, and the median hospitalization cost was $125 (range: $35.1-$414), with higher costs among those hospitalized for more than 7 days (P < .001). None of the patients had received rotavirus vaccination. Vaccine prices were comparable to or lower than median hospitalization costs, supporting the potential cost-effectiveness of including rotavirus vaccine in the national immunization program.
Related Concept Videos
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Bacterial Gastroenteritis
Cholera
Poliomyelitis
Respiratory Syncytial Virus Disease